BridgeMD
New treatment option for Glycogen Storage Disease Type I
Official title Dietary Treatment Strategies and Metabolic Control in Glycogen Storage Disease Type I
ClinicalTrials.gov ID: NCT06852612
What this study is testing
- What it's testing
- The present project will specifically assess metabolic effects of dietary interventions with controlled intake of fructose and fructose/galactose in GSDI, with the aim to provide evidence whether relaxed dietary restrictions of fructose and galactose may be justified in treatment recommendations at least for adults, which would considerably enlarge food choice in everyday life of the patients with an expected positive impact on the quality of life of patients with this rare disorder.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Genetically and/or enzymatically confirmed diagnosis of GSDI (GSDIa or GSDIb)
- Male or female ≥ 18y
- Restriction of fructose intake in usual dietary treatment
- Written informed consent
You likely can't join if
- Non-compliance with routine dietary treatment
- Pregnancy or lactation
- Liver transplant
- Recurrent hospitalisations due to metabolic decompensation within the last 12 months
- Severe chronic kidney disease with glomerular filtration rate (GFR) \< 30 ml/min
- For GSDIb: Severe, uncontrolled symptomatic inflammatory bowel disease
The study team makes the final eligibility decision.
Where it's taking place
- Bern, Switzerland
- Zurich, Switzerland
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bern, Switzerland; Zurich, Switzerland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.